-
1.发明授权Fusion protein comprising FK506 binding protein and DNA encoding the same 有权包含FK506结合蛋白的融合蛋白和编码该融合蛋白的DNA公开(公告)号：US07902346B2
公开(公告)日：2011-03-08
申请号：US12144890
申请日：2008-06-24
申请人： Soo Young Choi , Jinseu Park , Won Sik Eum , Dae-Won Kim , Jin-Hee Choi , Tae-Yoon Kim , Hyung-Joo Kwon
发明人： Soo Young Choi , Jinseu Park , Won Sik Eum , Dae-Won Kim , Jin-Hee Choi , Tae-Yoon Kim , Hyung-Joo Kwon
CPC分类号： C12N9/90 , C07K2319/01
摘要： Disclosed is a fusion protein containing a FK506 binding protein and a cell-transducing domain. Also, disclosed is a method of making the fusion protein and use of the fusion protein in a pharmaceutical or cosmetic composition. The cell-transducing domain is, for example, a PEP-1.
摘要翻译： 披露了含有FK506结合蛋白和细胞转导结构域的融合蛋白。 此外，还公开了在药物或化妆品组合物中制备融合蛋白并使用融合蛋白的方法。 细胞转导结构域是例如PEP-1。
-
2.发明申请FUSION PROTEIN COMPRISING FK506 BINDING PROTEIN AND METHOD OF MAKING AND USING THE SAME 有权包含FK506结合蛋白的融合蛋白及其制备和使用方法公开(公告)号：US20080280830A1
公开(公告)日：2008-11-13
申请号：US12144890
申请日：2008-06-24
申请人： Soo Young Choi , Jinseu Park , Won Sik Eum , Dae-Won Kim , Jin-Hee Choi , Tae-Yoon Kim , Hyung-Joo Kwon
发明人： Soo Young Choi , Jinseu Park , Won Sik Eum , Dae-Won Kim , Jin-Hee Choi , Tae-Yoon Kim , Hyung-Joo Kwon
CPC分类号： C12N9/90 , C07K2319/01
摘要： Disclosed is a fusion protein containing a FK506 binding protein and a cell-transducing domain. Also, disclosed is a method of making the fusion protein and use of the fusion protein in a pharmaceutical or cosmetic composition. The cell-transducing domain is, for example, a PEP-1.
摘要翻译： 披露了含有FK506结合蛋白和细胞转导结构域的融合蛋白。 此外，还公开了在药物或化妆品组合物中制备融合蛋白并使用融合蛋白的方法。 细胞转导结构域是例如PEP-1。
-
3.发明授权Eye drop composition for prevention and treatment of ophthalmic diseases containing fusion protein of FK506 binding protein 有权用于预防和治疗含有FK506结合蛋白的融合蛋白的眼科疾病的眼药水组合物公开(公告)号：US08962567B2
公开(公告)日：2015-02-24
申请号：US13985845
申请日：2011-04-06
申请人： Soo Young Choi , Dae Won Kim , Sung Ho Lee , Jinseu Park , Won Sik Eum
发明人： Soo Young Choi , Dae Won Kim , Sung Ho Lee , Jinseu Park , Won Sik Eum
CPC分类号： C12N9/90 , A61K38/00 , A61K38/16 , A61K38/52 , C07K7/06 , C07K14/001 , C07K2319/00 , C07K2319/10 , C12Y502/01008 , Y10S514/914
摘要： Disclosed is a treatment for ophthalmic diseases, more specifically, a pharmaceutical composition for treating ophthalmic diseases including a fusion protein of FK506 binding protein capable of penetrating into the ocular tissue as an active ingredient.
摘要翻译： 本发明涉及一种治疗眼科疾病的方法，更具体地说，涉及一种治疗眼科疾病的药物组合物，包括能够渗入眼组织的FK506结合蛋白的融合蛋白作为有效成分。
-
4.发明申请EYE DROP COMPOSITION FOR PREVENTION AND TREATMENT OF OPHTHALMIC DISEASES CONTAINING FUSION PROTEIN OF FK506 BINDING PROTEIN 有权用于预防和治疗含有FK506结合蛋白的融合蛋白的眼病的眼睑组合物公开(公告)号：US20130330368A1
公开(公告)日：2013-12-12
申请号：US13985845
申请日：2011-04-06
申请人： Soo Young Choi , Dae Won Kim , Sung Ho Lee , Jinseu Park , Won Sik Eum
发明人： Soo Young Choi , Dae Won Kim , Sung Ho Lee , Jinseu Park , Won Sik Eum
CPC分类号： C12N9/90 , A61K38/00 , A61K38/16 , A61K38/52 , C07K7/06 , C07K14/001 , C07K2319/00 , C07K2319/10 , C12Y502/01008 , Y10S514/914
摘要： Disclosed is a treatment for ophthalmic diseases, more specifically, a pharmaceutical composition for treating ophthalmic diseases including a fusion protein of FK506 binding protein capable of penetrating into the ocular tissue as an active ingredient.
摘要翻译： 本发明涉及一种治疗眼科疾病的方法，更具体地说，涉及一种治疗眼科疾病的药物组合物，包括能够渗入眼组织的FK506结合蛋白的融合蛋白作为有效成分。
-
-
-
搜索结果
4 条记录 (耗时 0.043 秒)
